Cholinesrterase drugs Flashcards
Nicotinic Receptor location
Neuromuscular end plate, Skeletal muscle, Autonomic ganglion cells
Muscarinic Location
Nerve, heart and smooth muscle, Gelands and endothelium
Direct Acting CAg
Acetylcholine Bethanechol Carbachol Cevimeline Nicotine Pilocarpine
Indirect acting Rev CAg
Ambenonium Donepezil Edrophonium Galantamine Neostigmine Physostigmine Rivastigmine
Indirect Acting Irr CAg
Echothiophate
Cholinomimetic (cholinergic) Drugs Short acting
Edrophonium
Cholinomimetic (cholinergic) Drugs
Intermediate to long acting
Carbamates
Very long acting Cholinomimetic (cholinergic) Drugs
Parathion
ACETYLCHOLINE CL Susc, Musc, Nico
Very
intermediate
intermediare
Methacholine Susc, Musc, Nico
V Little, Very, Intermediate
CARBACHOL CL Susc, Musc, Nico
Neg, Little, intermediate
Betanechol Susc, Musc, nico
Neg, Little, none
Acetylcholine
Direct Acting (Muscarinic)
Metacholine (No nicotinic action, resistant to Ache, like carbachol and
bethanechol
Act on both M and N receptors. Activates M1-M3 receptors in all peripheral tissues
Miotic for Eye surgery
CNS stimulation, miosis, cyclospasm, bronchoconstriction, excessive GI
and GU smooth muscle contraction, increased secretory activity of
sweat gland, airway; vasodilation (arises from M3 activation and
requires intact endothelium – Nitric oxide mediated
Results to increased secretion, smooth muscle contraction (except in
vascular smooth muscles where it causes relaxation) and changes in
heart rate; very short-lived duration of action: 5-30 sec, rapidly
hydrolyzed by AChe
Bethanechol
Carbachol USP 0.01% W/V
1 ml vial
A pack of 1 vial
Direct Acting (Muscarinic)
Carbachol (act on both muscarinic and nicotinic receptors)
Act on both M receptors only. Activates M1-M3 receptors
Bladder and bowel atony (post-surgery or spinal cord injury); congenital
megacolon
Cyclospasm, Diarrhea, Urinary urgency, Vasodilation (similar MOA with
Ach), Reflex tachycardia, Sweating
Both are resistant to hydrolysis of Ache – longer duration of action
Carbachol – use for glaucoma as a miotic agent
Neostigmine (an indirect acting cholinomimetic) is also another drug
useful for bladder and bowel atony (non obstructive type)
Pilocarpine
Direct Acting (Muscarinic)
Cevimeline (M3 selective)
Activates M3 receptors in ciliary muscle causing contraction of ciliary
body to facilitate aqueous humor outflow and diminish its rate of
secretion; increase salivation
Glaucoma, Sjogren syndrome, Sicca Syndrome, head and neck
irradiation
Miosis, Blurring of vision, increase salivation, Hypertension (after brief
period of hypotension due to activation of sympathetic postganglionic
M1 receptors
No effect of nicotinic receptors
Nicotine
Direct Acting (Nicotinic)
Lobeline and Varenicline (selective partial agonist at nicotinic receptor with 12-24
hour duration of action)
Lobeline and Varenicline (selective partial agonist at nicotinic receptor with 12-24
hour duration of action)
Smoking cessation
Generalized ganglionic stimulation (hypertension, tachycardia, nausea, vomiting and diarrhea
Activates all autonomic post ganglionic neurons (both sympathetic and
parasympathetic, hence generalized ganglionic stimulation) and skeletal muscle nm endplates
Nicotine in the CNS is associated with greater release of dopamine in the mesolimbic system (addicting effect) Smoke with nicotine (non fatal dose); avoid eating (40mg/2 cigarette)
Low dose and initial high dose Nicotine
Stimulate receptors depolarization of membrane and influx of Na and Ca
Large dose Nicotine
Stimulation followed by prolonged blockade of repolarization
Receptor: becomes refractory to stimulation
Toxicity: convulsions, fasciculations, and paralysis
Treatment: Atropine for muscarinic; symptomatic
approach
Nicotine: PNS
Nicotine – same on both parasympathetic and sympathetic
•CARDIOVASCULAR –SYMPATHOMIMETIC
•GASTROINTESTINAL-PARASYMPATHOMIMETIC
•Prolonged exposure may result in depolarizing
blockade of the ganglia
Primary autoimmune autonomic failure –
example of effect suppression on nicotinic
receptor function at the autonomic ganglia
Nicotine: Abstinence Syndrome
Irritability, restlessness, anxiety, headache, insomnia, GIT upset increased appetite, irritability, restlessness, anxiety headache, insomnia, GIT upset, increased appetite, craving to start smoking.
• Begins 24 hrs and last for weeks
Muscarinic Toxicity
Seen in overdosage of muscarinic agonist and in types of
mushroom (Inocybe); Amanita muscaria
Atropine (Cholinergic antagonist)
CNS stimulation, miosis, blurring of vision, bronchoconstriction,
excessive gastrointestinal and genitourinary smooth muscle
activity, increase secretory activity of the sweat glands, airway,
gastrointestinal tract, lacrimal glands; vasodilation
Symptoms of muscarinic poisoning is essentially similar with
organophosphate poisoning minus symptoms of nicotinic excess
In organophosphates: they are long acting acetylcholinesterase
inhibitor or indirect acting cholinomimetic
Mushroom Poisoning Rapid oneset
RAPID ONSET 15-30 MIN AFTER INGESTION SIGNS OF MUSCARINIC EXCESS OR MUSCARINIC SUPPRESSION ATROPINE 1-2 MG IS RECOMMENDED
MP Delayed onset
6-12 HRS
HEPATIC AND RENAL CELL INJURY ATROPINE NOT RECOMMENDED